JP Morgan Chase’s Akso Health Group AHG Stock Holding History

JP Morgan Chase’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,200	Closed	-$62K	–	5731
2018 Q4	$62K	Buy	8,200 +7,082	+633%	+$117K	﹤0.01%	5003
2018 Q3	$26K	Buy	+1,118	New	+$29K	﹤0.01%	5367

Other funds holding AHG

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase's AHG Position: Q1 2019 in Review

JP Morgan Chase sold out of Akso Health Group (AHG) in Q1 2019, closing a stake of 8,200 shares — an estimated $62K sold.

JP Morgan Chase first reported a position in AHG in Q3 2018 and held it in 2 quarters. The position peaked at $62K in Q4 2018. 13 funds tracked by Wall St. Rank hold AHG as of Q1 2019.

JP Morgan Chase reported no remaining Akso Health Group position as of Q1 2019 after selling out during the quarter.
JP Morgan Chase sold 8,200 Akso Health Group shares in Q1 2019, an estimated $62K.
JP Morgan Chase first reported a position in Akso Health Group in Q3 2018 and held it in 2 quarters.
JP Morgan Chase's Akso Health Group position peaked at $62K in Q4 2018.
13 funds tracked by Wall St. Rank held Akso Health Group as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.